Wednesday's Small-Cap Winners & Losers
American Technology (ATCO), meanwhile, traded some 23% higher to $3.98 after saying the U.S. Navy and Army chose the San Diego-based company's LRAD 500 acoustic hailing and warning device for small vessels and vehicles.
Children's footwear maker Stride Rite (SRR), which agreed to an $800 million takeout by Payless ShoeSource (PSS), surged 30.9% to $20.21 and provided strong support to the S&P SmallCap 600, but the index still weighed under the broader market's afternoon slide. The index slipped 2.09 points to 434.22.
Among those pulling down the tracker was Minneapolis medical-device maker Possis Medical (POSS), which plunged 9.8% to $12.09 after breaking even for the quarter ended April 30 to fall a nickel short of Thomson Financial's per-share earnings consensus for the quarter ended April 30.
Likewise for fellow components Pep Boys (PBY), an auto-parts retailer, and Maximus (MMS), a business-services firm. Pep Boys slid 5.6% to $18.82 after coming in below sales estimates for the quarter ended May 5, and Maximus was cut to hold from buy at Stifel Nicolaus, pressuring shares down 4.2% to $41.65.
Elsewhere in negative territory, Vion Pharmaceuticals (VION) took a 57.4% nosedive to 86 cents after the New Haven, Conn., biotech halted a late-phase study of leukemia drug Cloretazine "pending a detailed review of all of the data from the trial." TRM (TRMM), an Oregon-based purveyor of ATM and photocopy services, tumbled 25.5% to $1.81 after announcing dwindling fourth-quarter revenue and a widening loss vs. last year, as well as the resignation of Chief Executive Jeffrey Brotman, who will stay on as a non-executive chairman. His CEO role will be assumed by the current chief operating officer, Richard Stern, as of June 15.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV